Inverse Psoriasis: From Diagnosis to Current Treatment Options

References

• Omland SH, Gniadecki R. Psoriasis inversa: a separate identity or a variant of psoriasis vulgaris? Clin Dermatol. 2015;33(4):456–461. doi:10.1016/j.clindermatol.2015.04.00726051061
   PubMed Web of Science ®Google Scholar
• Syed ZU, Khachemoune A. Inverse psoriasis: case presentation and review. Am J Clin Dermatol. 2011;12(2):143–146. doi:10.2165/11532060-000000000-0000021184623
   PubMed Web of Science ®Google Scholar
• Fan X, Yang S, Sun LD, et al. Comparison of clinical features of HLA-Cw*0602-positive and negative psoriasis patients in a Han Chinese population. Acta Derm Venereol. 2007;87:335–340. doi:10.2340/00015555-025317598037
   PubMed Web of Science ®Google Scholar
• Fouere S, Adjadj L, Pawin H. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol. 2005;3(Suppl 19):2–6. doi:10.1111/j.1468-3083.2005.01329.x
   Web of Science ®Google Scholar
• Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Paediatr Drugs. 2015;17(5):373–384. doi:10.1007/s40272-015-0137-126072040
   PubMed Web of Science ®Google Scholar
• Reynolds KA, Pithadia DJ, Lee EB, Wu JJ. Treatments for inverse psoriasis: a systematic review. J Dermatolog Treat. 2019;1–23. doi:10.1080/09546634.2019.1620912
   Web of Science ®Google Scholar
• Cohen JM, Halim K, Joyce CJ, Patel M, Qureshi AA, Merola JF. Shedding light on the “hidden psoriasis”: a pilot study of the Inverse Psoriasis Burden of Disease (IPBOD) questionnaire. J Drugs Dermatol. 2016;15(8):1011–1016.27538004
   PubMed Web of Science ®Google Scholar
• Zampetti A, Tiberi S. Inverse psoriasis. Clin Med (Lond). 2015;15(3):311. doi:10.7861/clinmedicine.15-3-31126031992
   PubMed Web of Science ®Google Scholar
• Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis. 2010;10:470–478. doi:10.1016/S1473-3099(10)70101-820610329
   PubMed Web of Science ®Google Scholar
• Merola JF, Qureshi A, Husni ME. Underdiagnosed and undertreated psoriasis: nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails. Dermatol Ther. 2018;31(3):e12589. doi:10.1111/dth.2018.31.issue-329512290
   PubMed Web of Science ®Google Scholar
• Wilmer EN, Hatch RL. Resistant “candidal intertrigo”: could inverse psoriasis be the true culprit? J Am Board Fam Med. 2013;26(2):211–214. doi:10.3122/jabfm.2013.02.12021023471936
   PubMed Web of Science ®Google Scholar
• Weisenseel P, Reich K. Psoriasis inversa. Hautarzt. 2015;6:408–412. doi:10.1007/s00105-015-3628-7
   Web of Science ®Google Scholar
• Janniger CK, Schwartz RA, Szepietowski JC, Reich A. Intertrigo and common secondary skin infections. Am Fam Physician. 2005;72(5):833–838.16156342
   PubMed Web of Science ®Google Scholar
• Brandon A, Mufti A, Gary Sibbald R. Diagnosis and management of cutaneous psoriasis: a review. Adv Skin Wound Care. 2019;32(2):58–69. doi:10.1097/01.ASW.0000550592.08674.4330653184
   PubMed Web of Science ®Google Scholar
• Errichetti E, Lacarrubba F, Micali G, Stinco G. Dermoscopy of zoon’s plasma cell balanitis. J Eur Acad Dermatol Venereol. 2016;30(12):e209–e210. doi:10.1111/jdv.1353826670716
   PubMed Web of Science ®Google Scholar
• Errichetti E, Lallas A, Di Stefani A, et al. Accuracy of dermoscopy in distinguishing erythroplasia of queyrat from common forms of chronic balanitis: results from a multicentric observational study. J Eur Acad Dermatol Venereol. 2019;33(5):966–972. doi:10.1111/jdv.2019.33.issue-530468529
   PubMed Web of Science ®Google Scholar
• Micali G, Lacarrubba F, Massimino D, Schwartz RA. Dermatoscopy: alternative uses in daily clinical practice. J Am Acad Dermatol. 2011;64(6):1135–1146. doi:10.1016/j.jaad.2010.03.01021292346
   PubMed Web of Science ®Google Scholar
• Lacarrubba F, Ardigò M, Di Stefani A, Verzì AE, Micali G. Dermatoscopy and reflectance confocal microscopy correlations in nonmelanocytic disorders. Dermatol Clin. 2018;36(4):487–501. doi:10.1016/j.det.2018.05.01530201157
   PubMed Web of Science ®Google Scholar
• Micali G, Verzì AE, Lacarrubba F. Alternative uses of dermoscopy in daily clinical practice: an update. J Am Acad Dermatol. 2018;79(6):1117–1132.e1. doi:10.1016/j.jaad.2018.06.02129920317
   PubMed Web of Science ®Google Scholar
• Micali G, Lacarrubba F, Musumeci ML, Massimino D, Nasca MR. Cutaneous vascular patterns in psoriasis. Int J Dermatol. 2010;49(3):249–256. doi:10.1111/ijd.2010.49.issue-320465659
   PubMed Web of Science ®Google Scholar
• Lacarrubba F, Musumeci ML, Ferraro S, Stinco G, Verzì AE, Micali G. A three-cohort comparison with videodermatoscopic evidence of the distinct homogeneous bushy capillary microvascular pattern in psoriasis vs atopic dermatitis and contact dermatitis. J Eur Acad Dermatol Venereol. 2016;30(4):701–703. doi:10.1111/jdv.1299825688473
   PubMed Web of Science ®Google Scholar
• Nasca MR, Lacarrubba F, Caltabiano R, Micali G. Image gallery: reproduction of the auspitz sign by videodermatoscopy, confocal microscopy and horizontal histopathology. Br J Dermatol. 2019;180(6):e178. doi:10.1111/bjd.2019.180.issue-631157450
   PubMed Web of Science ®Google Scholar
• Micali G, Nardone B, Scuderi A, Lacarrubba F. Videodermatoscopy enhances the diagnostic capability of palmar and/or plantar psoriasis. Am J Clin Dermatol. 2008;9(2):119–122. doi:10.2165/00128071-200809020-0000518284266
   PubMed Web of Science ®Google Scholar
• Lacarrubba F, Nasca MR, Micali G. Videodermatoscopy enhances diagnostic capability in psoriatic balanitis. J Am Acad Dermatol. 2009;61(6):1084–1086. doi:10.1016/j.jaad.2009.04.01219925937
   PubMed Web of Science ®Google Scholar
• Musumeci ML, Lacarrubba F, Verzì AE, Micali G. Evaluation of the vascular pattern in psoriatic plaques in children using videodermatoscopy: an open comparative study. Pediatr Dermatol. 2014;31(5):570–574. doi:10.1111/pde.2014.31.issue-524383819
   PubMed Web of Science ®Google Scholar
• Musumeci ML, Lacarrubba F, Catalfo P, Scilletta B, Micali G. Videodermatoscopy evaluation of the distinct vascular pattern of psoriasis improves diagnostic capability for inverse psoriasis. G Ital Dermatol Venereol. 2017;152(1):88–90. doi:10.23736/S0392-0488.16.05212-326377539
   PubMed Web of Science ®Google Scholar
• Rosina P, Zamperetti MR, Giovannini A, Girolomoni G. Videocapillaroscopy in the differential diagnosis between psoriasis and seborrheic dermatitis of the scalp. Dermatology. 2007;214(1):21–24. doi:10.1159/00009690817191043
   PubMed Web of Science ®Google Scholar
• Borghi A, Virgili A, Corazza M. Dermoscopy of inflammatory genital diseases: practical insights. Dermatol Clin. 2018;36(4):451–461. doi:10.1016/j.det.2018.05.01330201154
   PubMed Web of Science ®Google Scholar
• Lacarrubba F, Verzì AE, Ardigò M, Micali G. Handheld reflectance confocal microscopy, dermatoscopy and histopathological correlation of common inflammatory balanitis. Skin Res Technol. 2018;24(3):499–503. doi:10.1111/srt.2018.24.issue-329457262
   PubMed Web of Science ®Google Scholar
• Lacarrubba F, Pellacani G, Gurgone S, Verzì AE, Micali G. Advances in non-invasive techniques as aids to the diagnosis and monitoring of therapeutic response in plaque psoriasis: a review. Int J Dermatol. 2015;54(6):626–634. doi:10.1111/ijd.2015.54.issue-625772034
   PubMed Web of Science ®Google Scholar
• Verzì AE, Lacarrubba F, Caltabiano R, Broggi G, Musumeci ML, Micali G. Reflectance confocal microscopy features of plaque psoriasis overlap with horizontal histopathological sections: a case series. Am J Dermatopathol. 2019;41(5):355–357. doi:10.1097/DAD.000000000000129730640760
   PubMed Web of Science ®Google Scholar
• Khosravi H, Siegel MP, Van Voorhees AS, Merola JF. Treatment of inverse/intertriginous psoriasis: updated guidelines from the medical board of the national psoriasis foundation. J Drugs Dermatol. 2017;16(8):760–766.28809991
   PubMed Web of Science ®Google Scholar
• Kreuter A, Sommer A, Hyun J, et al. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. Arch Dermatol. 2006;142(9):1138–1143. doi:10.1001/archderm.142.9.113816983001
   PubMedGoogle Scholar
• Lebwohl MG, Tan MH, Meador SL, Singer G. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol. 2001;44(1):77–82. doi:10.1067/mjd.2001.11004611148481
   PubMed Web of Science ®Google Scholar
• Kalb RE, Bagel J, Korman NJ, et al., National Psoriasis Foundation. Treatment of intertriginous psoriasis: from the medical board of the national psoriasis foundation. J Am Acad Dermatol. 2009;60(1):120–124. doi:10.1016/j.jaad.2008.06.04119103363
   PubMed Web of Science ®Google Scholar
• Malecic N, Young H. Tacrolimus for the management of psoriasis: clinical utility and place in therapy. Psoriasis (Auckl). 2016;6:153–163. doi:10.2147/PTT.S10123329387602
   PubMedGoogle Scholar
• Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004;51(5):723–730. doi:10.1016/j.jaad.2004.07.01115523350
   PubMed Web of Science ®Google Scholar
• Gribetz C, Ling M, Lebwohl M, et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol. 2004;51(5):731–738. doi:10.1016/j.jaad.2004.06.01015523351
   PubMed Web of Science ®Google Scholar
• Freeman AK, Linowski GJ, Brady C, et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol. 2003;48:564–568. doi:10.1067/mjd.2003.16912664020
   PubMed Web of Science ®Google Scholar
• Ezquerra GM, Regana MS, Acosta EH, Millet PU. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol. 2006;5:334–343.16673800
   PubMedGoogle Scholar
• Brune A, Miller DW, Lin P, Cotrim-Russi D, Paller AS. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol. 2007;24:76–80. doi:10.1111/j.1525-1470.2007.00341.x17300658
   PubMed Web of Science ®Google Scholar
• Ortonne JP, Humbert P, Nicolas JF, et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 ug g-1 ointment and calcipotriol 50 ug g-1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol. 2003;148(2):326–333. doi:10.1046/j.1365-2133.2003.05228.x12588387
   PubMed Web of Science ®Google Scholar
• Dattola A, Silvestri M, Bennardo L, et al. Update of calcineurin inhibitors to treat inverse psoriasis: a systematic review. Dermatol Ther. 2018;31(6):e12728. doi:10.1111/dth.v31.630295379
   PubMed Web of Science ®Google Scholar
• Kienbaum S, Lehmann P, Ruzicka T. Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol. 1996;135(4):647–650. doi:10.1111/j.1365-2133.1996.tb03851.x8915166
   PubMed Web of Science ®Google Scholar
• Noah PW. The role of microorganisms in psoriasis. Semin Dermatol. 1990;9(4):269–276.2285571
   PubMedGoogle Scholar
• Rosenberg EW, Noah PW, Skinner RB Jr, Vander Zwaag R, West SK, Browder JF. Microbial associations of 167 patients with psoriasis. Acta Derm Venereol Suppl (Stockh). 1989;146:72–74.2609890
   PubMedGoogle Scholar
• Flytström I, Bergbrant IM, Bråred J, Brandberg LL. Microorganisms in intertriginous psoriasis: no evidence of candida. Acta Derm Venereol. 2003;83(2):121–123. doi:10.1080/0001555031000746312735640
   PubMed Web of Science ®Google Scholar
• Arnold WP, Van Der Meer YG. Does adding of chlorhexidine 0.5% to topical corticosteroids enhance efficacy in the treatment of atopic dermatitis and inverse psoriasis? Results of a double-blind study. Ned Tijdschr Dermatol Venereol. 2005;15(8):340–342.
   Google Scholar
• Leigheb G, Gallus D, Spano G. Treatment of psoriasis with an antiseptic combination, in a double-blind comparison versus eosin. G Ital Dermatol Venereol. 2000;135(1):107‐14.
   Google Scholar
• Ješe R, Perdan-Pirkmajer K, Dolenc-Voljč M, Tomšič M. A case of inverse psoriasis successfully treated with adalimumab. Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(1):21–23.24638868
   PubMedGoogle Scholar
• Campos MA, Varela P, Baptista A, Moreira AI. Inverse psoriasis treated with ustekinumab. BMJ Case Rep. 2016;2016. doi:10.1136/bcr-2015-212769
   Google Scholar
• Ryan C, Menter A, Guenther L, et al.; IXORA-Q Study Group. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis. Br J Dermatol. 2018;179(4):844–852. doi:10.1111/bjd.2018.179.issue-429747232
   PubMed Web of Science ®Google Scholar
• Mafong EA, Friedman PM, Kauvar AN, Bernstein LJ, Alexiades-Armenakas M, Geronemus RG. Treatment of inverse psoriasis with the 308 nm excimer laser. Dermatol Surg. 2002;28(6):530–532. doi:10.1046/j.1524-4725.2002.12005.x12081686
   PubMed Web of Science ®Google Scholar
• Zanchi M, Favot F, Bizzarini M, Piai M, Donini M, Sedona P. Botulinum toxin type-A for the treatment of inverse psoriasis. J Eur Acad Dermatol Venereol. 2008;22(4):431–436. doi:10.1111/j.1468-3083.2007.02457.x18363911
   PubMed Web of Science ®Google Scholar